The latest closing stock price for Alnylam Pharmaceuticals as of March 27, 2025 is 271.02.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $37,717 today, roughly 38 times their original investment - a 19.02% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 12.3% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.97, which is 47.6% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 234.22.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $37,717 today, roughly 38 times their original investment - a 19.02% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 12.3% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.97, which is 47.6% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 234.22.